- An Obesity Drug Prevents Covid Deaths, Study Suggests The New York Times
- Novo rekindles heart failure hopes for semaglutide with new pooled analysis FiercePharma
- Ozempic hailed as ‘fountain of youth’ The Telegraph
- Wegovy cut patients’ chances of dying from Covid-19, new analysis shows STAT
- Ozempic and Wegovy cut risk of severe COVID in people with obesity, says Harvard study The Boston Globe
Credit: Source link

























